Ahmadi Z, Sandberg J, Shannon-Honson A, Vandersman Z, Currow DC, Ekström M. Is chronic breathlessness less recognised and treated compared with chronic pain? A case-based randomised controlled trial. Eur Respir J. 2018; 52:(3)

Bajwah S, Wilcock A, Towers R Managing the supportive care needs of those affected by COVID-19. Eur Respir J. 2020; 55:(4)

Booth S, Johnson MJ. Improving the quality of life of people with advanced respiratory disease and severe breathlessness. Breathe (Sheff). 2019; 15:(3)198-215

Borge CR, Wahl AK, Moum T. Association of breathlessness with multiple symptoms in chronic obstructive pulmonary disease. J Adv Nurs. 2010; 66:(12)2688-2700

Bove DG, Midtgaard J, Kaldan G, Overgaard D, Lomborg K. Home-based COPD psychoeducation: A qualitative study of the patients' experiences. J Psychosom Res. 2017; 98:71-77

British Lung Foundation. Estimating the economic burden of respiratory illness in the UK. 2017. (accessed 9 May 2022)

Chin C, Booth S. Managing breathlessness: a palliative care approach. Postgrad Med J. 2016; 92:(1089)393-400

Polypharmacy and medicines optimisation. Making it safe and sound. 2013. (accessed 9 May 2022)

Eriksen CU, Kyriakidis S, Christensen LD Medication-related experiences of patients with polypharmacy: a systematic review of qualitative studies. BMJ Open. 2020; 10:(9)

Greater Manchester and Eastern Cheshire Strategic Clinical Networks. Palliative care pain & symptom control guidelines for adults for staff providing generalist palliative care. 2019. (accessed 23 May 2022)

Hutchinson A, Barclay-Klingle N, Galvin K, Johnson MJ. Living with breathlessness: a systematic literature review and qualitative synthesis. Eur Respir J. 2018; 51:(2)

Johnson MJ, Currow DC. Opioids for breathlessness: a narrative review. BMJ Support Palliat Care. 2020; 10:(3)287-295

Breathlessness. 2021. (accessed 9 May 2022)

Long VJE, Cheung YB, Qu D Validity and reliability of the English and translated Chinese versions of the Integrated Palliative care Outcome Scale (IPOS) in Singapore. BMC Palliat Care. 2021; 20:(1)

Marshall K. Breathlessness: causes, assessment and non-pharmacological management. Nurs Times. 2020; 116:(9)24-26

Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017; 17:(1)

Medical Research Council. MRC Dyspnoea Scale/MRC breathlessness scale. 2021. (accessed 24 May 2022)

Miravitlles M, Ribera A. Understanding the impact of symptoms on the burden of COPD. Respir Res. 2017; 18:(1)

NHS England. Emergency Health Care Plan. 2021. (accessed 9 May 2022)

NHS Scotland. Scottish Palliative Care Guidelines Symptom Control Breathlessness. 2021. (accessed 9 May 2022)

NHS. Overview Bronchodilators. 2019c. (accessed 23 May 2022)

NHS. Treatment: Bronchiectasis. 2021. (accessed 9 May 2022)

National Institute for Health and Care Excellence. Diagnosis of chronic obstructive pulmonary disease. 2022. (accessed 9 May 2022)

O'Driscoll BR, Howard LS, Earis J, Mak V. British cThoracic Society Guideline for oxygen use in adults in healthcare and emergency settings. BMJ Open Respir Res. 2017; 4:(1)

Public Health England. Respiratory Disease: applying All our Health. 2019. (accessed 9 May 2022)

Senderovich H, Yendamuri A. Management of breathlessness in palliative care: inhalers and dyspnea-a literature review. Rambam Maimonides Med J. 2019; 10:(1)

Sung JH, Brown MC, Perez-Cosio A Acceptability and accuracy of patient-reported outcome measures (PROMs) for surveillance of breathlessness in routine lung cancer care: A mixed-method study. Lung Cancer. 2020; 147:1-11

World Health Organization. Medication without Harm. 2017. WHO global patient safety challenge. (accessed 9 May 2022)

Improving outcomes for people living with breathlessness

02 June 2022
Volume 33 · Issue 6


Breathlessness affects many people living in the community. Lucy Tymon and Catherine Best look at how practice nurses can improve outcomes in those living with this distressing symptom

The need for a holistic assessment is an essential element in the management of breathlessness in both chronic and advanced disease and requires a multidisciplinary and multifactorial approach to the safe and effective delivery of quality patient care. Although a multitude of potential interventions exist, these should be considered carefully alongside the need to maintain comfort and the patient's wishes. With this in mind, this article explores a number of pharmacological and non-pharmacological approaches to patient care in chronic and advanced disease, the emphasis being on patient choice, patient understanding and the need for compassion, often at a time when patients are living through, what could potentially be, their last few months of life.

In 2017 a report published by the British Lung Foundation (BLF) highlighted the staggering impact of lung disease in the UK (BLF, 2017); an impact which leads to 115 000 people dying from lung disease every year (Public Health England, 2019). With the impact of diagnosis posing a significant burden on the health of those who, for example, have a diagnosis of chronic obstructive pulmonary disease (COPD) – a burden which includes, breathlessness, cough, sputum production, wheezing, chest tightness and congestion (Miravitlls and Ribera, 2017) – and with associated costs to the NHS exceeding £11 billion annually (BLF, 2017), it is not surprising that The NHS Long Term Plan identifies the management of respiratory disease as a clinical priority (NHS, 2019a).

Furthermore, these figures are undeniably of grave concern when considering the ageing UK population, the need to reduce avoidable hospital admissions and the ever-increasing associated healthcare costs (NHS, 2019a).

Register now to continue reading

Thank you for visiting Practice Nursing and reading some of our peer-reviewed resources for general practice nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month